BACKGROUND: Postpartum depression and pelvic floor disorders are both common conditions that affect women; however, the association between the 2 has yet to be determined. OBJECTIVE: The aims of our study are to: (1) determine the prevalence of a positive postpartum depression screen in a specialty postpartum perineal clinic, and (2) identify risk factors for postpartum depression in this population. STUDY DESIGN: A retrospective chart review was performed of 294 women referred to a specialty postpartum perineal clinic at the University of Michigan from March 30, 2012, through May 3, 2016. Women who completed a new patient intake form, including the Edinburgh Postnatal Depression Scale, were included. The prevalence of a positive Edinburgh Postnatal Depression Scale screen (!10) was determined. Bivariate analyses were used to compare demographics, delivery characteristics, referral indications, and postpartum pelvic floor symptoms between women with and without a positive Edinburgh Postnatal Depression Scale screen. Significant variables identified in the analyses were then used to perform logistic regression to identify factors independently associated with a positive Edinburgh Postnatal Depression Scale screen. RESULTS: In all, 15.6% (46/294) of women had a positive postpartum depression screen. Average age was 30.6 AE 4.8 years, average body mass index was 28.9 AE 5.06 kg/m 2 , 68.0% (200/294) were Caucasian, 79.6% (234/294) were primiparous, and 86.0% (245/285) were breastfeeding. Using multivariable logistic regression, women with a positive postpartum depression screen had higher odds of being non-Caucasian (adjusted odds ratio, 2.72; 95% confidence interval, 1.27e5.832; P ¼ .01), having a history of depression and/or anxiety (adjusted odds ratio, 2.77; 95% confidence interval, 1.23e6.24; P ¼ .01), having been referred for pain (adjusted odds ratio, 2.61; 95% confidence interval, 1.24e5.49; P ¼ .01), and reporting urinary incontinence during and after pregnancy (adjusted odds ratio, 3.81; 95% confidence interval, 1.57e9.25; P ¼ .003). CONCLUSION: Urinary incontinence during and after pregnancy and referral for pain were pelvic floor symptoms independently associated with a positive postpartum depression screen in women referred to a specialty perineal clinic. Therefore, consideration should be given to depression screening in women presenting with perinatal urinary incontinence and persistent postpartum pain, as these women may be at increased risk of developing postpartum depression.
Introduction
Postpartum depression (PPD) and pelvic floor disorders are both common conditions that affect women. Pelvic floor disorders are often viewed as conditions affecting the older, postmenopausal population, while PPD occurs in younger, reproductive-aged women. Despite the difference in age of onset, common risk factors for both conditions are pregnancy and childbirth.
PPD affects 10-16% of women during the first 12 months after delivery.
1 PPD shares many common risk factors with major depression unrelated to pregnancy, such as history of depression, emotional stress, and poor socioeconomic status. 2 Outside of the postpartum state, women with depression are known to have a 30% increased prevalence of urinary incontinence (UI), 3 and there are emerging data showing an increased prevalence of fecal incontinence and pelvic organ prolapse with depression as well. [4] [5] [6] Pelvic pain disorders, including chronic pelvic pain and dyspareunia, also share an association with depression. [7] [8] [9] Despite this evidence, however, the association between pelvic floor symptoms and PPD has yet to be determined.
At our institution, postpartum women who have pelvic floor symptoms related to recent delivery, or whose delivery characteristics place them at high risk for birth injury, are referred to a specialty postpartum perineal clinic where routine PPD screening is performed as part of their new patient intake form. Therefore, the aims of our study are to: (1) determine the prevalence of a positive PPD screen in this specialty clinic, and (2) identify risk factors for PPD unique to this population.
Materials and Methods
We performed a retrospective chart review of women who were referred to the Michigan Healthy Healing After Delivery (MHHAD) clinic at the University of Michigan from March 30, 2012, through May 3, 2016 . This study received approval from the institutional review board at the University of Michigan (HUM00102114). Informed consent was waived due to use of deidentified data.
The MHHAD clinic is a specialty clinic staffed by urogynecologists and specially trained nurses. Ancillary Original Research ajog.org services frequently utilized include lactation support, pelvic floor physical therapy, social work, and referral to a postpartum/perinatal mood clinic. Women up to 1 year postpartum can be referred to the MHHAD clinic for any pelvic floor symptom. Common indications for referral include follow-up of complex perineal lacerations and/or obstetric anal sphincter injuries (OASIS) (ie, third-or fourth-degree lacerations), delayed healing or other complications related to perineal lacerations, UI, anal incontinence or other defecatory dysfunction, pelvic organ prolapse, urinary retention, pelvic pain, and dyspareunia/sexual dysfunction. At our institution, it is customary for most women with an OASIS to be referred to the MHHAD clinic for follow-up, education, and counseling regarding their perineal laceration.
For this study, women were included if a new patient intake form was available in our electronic medical records system. Demographics, medical history (including a history of depression and/ or anxiety), chronic pain conditions (eg, fibromyalgia, chronic pelvic pain, chronic back pain, migraine or chronic headaches, irritable bowel syndrome, dyspareunia, dysmenorrhea, and endometriosis), delivery characteristics, indication for referral, and questionnaire data were collected via chart review. Patient-reported pelvic floor symptoms were derived from the MHHAD intake questionnaire, which includes "yes/no" questions about UI and fecal incontinence, both current (ie, postpartum) and during pregnancy (eg, "Are you leaking urine?" and "Did you leak urine during your pregnancy?"). UI was quantified using the 8-item, validated Leakage Index developed by Antonakos et al 10 that assess urinary symptoms over the prior month. Scores range from 0-8, with higher scores indicating more incontinence, and questions address both stress and urgency symptoms. The Fecal Incontinence Severity Index 11 was used to quantify anal incontinence symptoms. The McGill Short Form 12 and Present Pain Index 13 are 2 validated tools used to describe and quantify pain.
The Edinburgh Postnatal Depression Scale (EPDS) is used to screen for PPD. The EPDS is the most widely used, validated PPD screening tool 14 ; it consists of 10 items, with responses scored as 0-3. Total scores range from 0-30, with higher scores reflecting an increased risk of PPD. We defined a positive PPD screen as a score of !10 on the EPDS. 15 We compared demographics, delivery characteristics, and postpartum pelvic floor symptoms between women with and without a positive PPD screen using bivariate analyses. Significant variables identified in the analyses were then used to perform logistic regression to identify factors independently associated with a positive PPD screen. Statistical analyses were generated using statistics software (SPSS, Version 21.0; IBM Corp, Armonk, NY).
Results
Of the 382 new patients seen in the MHHAD clinic during the study period, questionnaire data for 294 were available for analyses. Average age was 30.6 AE 4. Compared to women included in this study, the 88 women excluded due to missing questionnaire data had lower mean body mass index, higher parity, and a lower prevalence of OASIS (data not shown). Remaining demographic and delivery characteristics were similar (data not shown).
Overall, 15.6% (46/294) screened positive for PPD (EPDS score !10). Table 1 shows the bivariate comparisons of women with and without a positive PPD screen. Groups were similar in terms of basic demographics. Women with a positive PPD screen more frequently had a history of depression and/or anxiety (37.0% vs 17.7%, P ¼ .003), but the prevalence of chronic pain disorders, dyspareunia, dysmenorrhea, and/or endometriosis did not differ significantly. Infant weights and prevalence of operative vaginal delivery and OASIS were similar between groups.
UI during pregnancy was reported in 30.8% (88/286), postpartum UI was present in 22.1% (65/284), and 12.6% (37/282) of women had both. The prevalence of UI during pregnancy and postpartum was significantly higher among women with a positive vs negative PPD screen; however, Leakage Index scores were similar (Table 1) . Nearly 50% of women with a positive PPD screen reported UI during pregnancy and 35% had postpartum UI. Of the 88 women who reported UI during pregnancy, just over half had resolution of this symptom postpartum (58%, N ¼ 51); however, 42.0% (N ¼ 37) had persistent UI at the time of clinic evaluation. Almost 30% of women with a positive PPD screen had UI both during and after pregnancyea prevalence 3 times greater than that of women with a negative PPD screen.
Prevalence of anal incontinence and Fecal Incontinence Severity Index scores (reflecting anal incontinence over the previous month) were similar among groups. Of those who responded to questions about anal incontinence, daily flatal incontinence was reported by nearly 40% of women both with and without a positive screen.
Nearly half of women (48.6%, 143/ 294) were still using ibuprofen and/or acetaminophen for pain control; the prevalence was similar between those with and without a positive PPD screen (52.2% [24/46] Table 1 were not statistically different between women referred for pain vs other referral indications (data not shown).
Using the variables that were significant in bivariate analyses, and controlling for age and race, multivariable logistic regression was then used to determine factors independently associated with a positive PPD screen ( Table 2 ). The variable reflecting UI both during and after pregnancy was selected for use in the final model because of all the UI variables, it had the strongest association with a positive PPD screen in bivariate analyses. In logistic regression, women reporting UI both during and after pregnancy had nearly 4-fold increased odds of a positive PPD screen, which was the strongest association in the model. Non-Caucasian race, referral for pain, and history of depression and/or anxiety were also independently associated with increased odds of a positive PPD screen. When "UI during pregnancy" was used in the model, it was also independently associated with a positive PPD screen (adjusted odds ratio, 2.349; 95% confidence interval, 1.168e4.725; P ¼ .017) and the significance of the other variables remained unchanged. Finally, "UI postpartum" was used in the model and was marginally significant (adjusted odds ratio, 2.108; 95% confidence interval, 0.991e4.484; P ¼ .053), while significance of the other variables remained unchanged.
Comment
In this study of women at high risk for or experiencing pelvic floor symptoms following vaginal delivery, 15.6% screened positive for PPD, a rate similar to that reported in the general postpartum population. 1, 16 We identified 2 unique risk factors for PPD in this population: UI and referral for pain.
While the relationship between depression and UI has been well described in the nonpregnant population, very little is known about this association in pregnancy and the postpartum period. [16] [17] [18] In 1 of the few studies regarding UI and PPD, Hullfish et al 16 reported a significant association between urgency UI scores and a positive PPD screen. Our results extend the literature because we found that UI during pregnancy has an even stronger association with a positive PPD screen compared to postpartum UI alone. Furthermore, our study was not limited to urgency UI.
The overall prevalence of UI during pregnancy in the current study was 30.8%, which is consistent with prior studies 19, 20 ; however, in women with a positive PPD screen, the prevalence was nearly 50%. Even after controlling for a history of depression/anxiety, women Original Research GYNECOLOGY ajog.org with UI during pregnancy had 235% increased odds of a positive PPD screen, and if UI was also present in the postpartum period, the odds increased 380%. This is an important finding, because over half of women with PPD also have depression during or preceding pregnancy. 21 The American Congress of Obstetricians and Gynecologists (ACOG) recommends depression screening at least once during the perinatal periodepregnancy thru 12 months postpartum 22 ebut does not specifically recommend routine antenatal depression screening. ACOG Committee Opinion no. 630 provides several validated screening tools for depression during pregnancy. 22 However, given the strong association between UI during pregnancy and PPD, the presence of antenatal UI may help identify women at high risk for depression during pregnancy, which could present an opportunity for early diagnosis, treatment, and prevention of PPD. We propose screening pregnant women during routine obstetrical visits with a simple question such as "Do you have bothersome leakage of urine?" The "Yes" responses could be followed up with a short validated questionnaire such as the Urinary Leakage Index, 10 the severity index of Sandvik et al, 23 or the Michigan Incontinence Symptom Index. 24 Referral for pain was also identified as independently associated with a positive PPD screen. Pelvic pain is a well-known risk factor for depression outside of the perinatal time, 7 and we found referral for pain to increase the odds of a positive PPD screen by 2.6-fold. However, the prevalence of chronic pain disorders, dyspareunia, dysmenorrhea, and/or endometriosis did not differ between women with a negative vs positive PPD screen. On average, women referred for pain were seen at 6 weeks postpartum, or 3 weeks later than women referred for other reasons. This likely reflects the fact that women referred for pain had persistent pain beyond that expected with normal postpartum recovery. This finding suggests that PPD screening should be considered in women with persistent pain at or beyond the 6-week postpartum period.
History of depression and/or anxiety and non-Caucasian race were other factors we identified as being associated with a positive PPD screen; both findings have precedence in the literature. Prior studies have reported that the risk of PPD more than doubles for women with a history of depression prior to pregnancy 25 ; we found 2.8-fold increased odds. In a study by Howell et al, 26 African American and Hispanic women had 2-fold increased odds of PPD symptoms compared to Caucasian women; in the current study, we found 2.7-fold increased odds among women of non-Caucasian race.
We recognize that our findings may not be generalizable to a general postpartum population given the nature of the MMHAD clinic's specialty referral base. Furthermore, as our study was cross-sectional in design, we lack longterm follow-up of any of these conditions. We were unable to control for a variety of risk factors for PPD such as socioeconomic status, insurance status, history of domestic violence, unintended pregnancy, and life stressors. 27 While the questions regarding UI during and after pregnancy did not assess onset, severity, duration, or characteristics of symptoms, the simplicity of the questions could potentially make perinatal screening for UI more easily incorporated into a general obstetrics practice. Our study also lacks objective assessment of UI such as positive cough stress test, voiding diaries, or pad tests. We may have been underpowered to detect differences in uncommon symptoms like fecal incontinence. Finally, patients are typically seen in our clinic earlier than the routine 6-week postpartum visit, which again may affect our results, as some pelvic floor symptoms may improve with time. However, the earlier follow-up may be beneficial for some women with a positive PPD screen, as they receive a referral to psychiatric care sooner than would occur otherwise.
Strengths of our study include the use of validated instruments in assessing PPD and pelvic floor symptoms, use of a standardized questionnaire for all subjects, and a relatively large sample size. ajog.org
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In summary, subjectively reported UI during and after pregnancy and referral for pain were significantly associated with a positive PPD screen in women at high risk for pelvic floor symptoms who were referred to a specialty perineal clinic. Risk of a positive PPD screen was highest in women who had UI during and after pregnancy. Therefore, screening for depression should be considered in women with UI during pregnancy and also in postpartum women with persistent UI or pain. n
